Literature DB >> 30268654

Hepatoprotection of Herpetospermum caudigerum Wall. against CCl4-induced liver fibrosis on rats.

Ming-Hui Li1, Xin Feng2, Da Ji Deng Ba3, Cheng Chen4, Ling-Yu Ruan5, Yue-Xiao Xing6, Lv-Yi Chen7, Ge-Jia Zhong8, Jun-Song Wang9.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Herpetospermum caudigerum Wall. (HCW) is a traditional Tibetan medicine, which has been used to ameliorate liver injuries in the folk. AIM OF THE STUDY: Liver fibrosis has been recognized as a major lesion of the liver that leads to liver cirrhosis/hepatocarcinoma and even to death in the end. This study aims to demonstrate the protective effect of HCW against CCl4-induced liver injury in rats and to explore the underlying mechanisms.
MATERIALS AND METHODS: Hepatic fibrosis was induced by intraperitoneal injection of CCl4. Liver function markers, fibrosis markers, serum anti-oxidation enzymes as well as elements levels were determined. Serum and liver tissues were subjected to NMR-based metabolomics and multivariate statistical analysis.
RESULTS: HCW could significantly reduce the elevated levels of fibrosis markers such as hyaluronidase, laminin, Type III procollagen and Type IV collagen in the serum, improve the activities of the antioxidant enzymes, and effectively reverse the abnormal levels of elements in liver fibrosis rats. Correlation network analysis revealed that HCW could treat liver fibrosis by ameliorating oxidative stress, repairing the impaired energy metabolisms and reversing the disturbed amino acids and nucleic acids metabolisms.
CONCLUSION: This integrated metabolomics approach confirmed the validity of the traditional use of HCW in the treatment of liber fibrosis, providing new insights into the underlying mechanisms.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CCl(4); Hepatic fibrosis; Herpetospermum caudigerum Wall.; Metabolomics; Network analysis; Tibetan medicine

Mesh:

Substances:

Year:  2018        PMID: 30268654     DOI: 10.1016/j.jep.2018.09.033

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  4 in total

Review 1.  Metabolomic and Lipidomic Biomarkers for Premalignant Liver Disease Diagnosis and Therapy.

Authors:  Diren Beyoğlu; Jeffrey R Idle
Journal:  Metabolites       Date:  2020-01-28

2.  Metabolomic Mechanisms of Radix Fici Hirtae against Carbon Tetrachloride-Induced Acute Liver Damage in Mice.

Authors:  Fang-Yu Zhou; Ting Quan; Shi-Jian Xiang; Hui Li; Hui-Yuan Chen; Yu-Xuan Yang; Sha-Sha Li
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-17       Impact factor: 2.650

3.  Exploration of the Protective Mechanism of Naringin in the Acetaminophen-Induced Hepatic Injury by Metabolomics.

Authors:  Zihan Lin; Guanzhen Wang; Wei Gu; Shengchao Zhao; Ziyi Shen; Wei Liu; Guodong Zheng; Baizhong Chen; Yi Cai; Mingxi Li; Chunpeng Craig Wan; Tingdong Yan
Journal:  Oxid Med Cell Longev       Date:  2022-09-16       Impact factor: 7.310

4.  Efficiency of Sophora flavescens-Fructus Ligustri Lucidi Drug Pairs in the Treatment of Liver Fibrosis Based on the Response Surface Method.

Authors:  Shuhan Chu; Hongxu Zhang; Lixin Ding
Journal:  Evid Based Complement Alternat Med       Date:  2019-04-01       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.